Rae Hyung Kang

Prof. Rae Hyung Kang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CSCho Suhyeon
Cho Suhyeon
Morteza RasoulianboroujeniMorteza Rasoulianboroujeni
Morteza Rasoulianboroujeni
RKRae Hyung Kang
Rae Hyung Kang
GKGlen Kwon
Glen Kwon
Polymeric micelles are promising nanocarriers for hydrophobic drug delivery, offering enhanced solubility, circulation time, and targeted release. This review presents a comprehensive evaluation of micelle preparation strategies, spanning conventional methods such as direct dissolution, dialysis, and thin-film hydration to emerging techniques including microfluidics, supercritical fluids, stimuli-responsive systems, and PEG-assisted assembly. Each method is compared in terms of scalability, reproducibility, solvent use, and regulatory compatibility. Among them, PEG-assisted methods show particular promise due to their simplicity and industrial readiness. We also explore the impact of fabrication strategy on drug loading, stability, and therapeutic efficacy across applications in cancer, infection, and inflammation. Finally, the review discusses key challenges in storage, manufacturing, and regulation, and highlights potential solutions through Quality-by-Design and scalable process integration. These insights provide guidance for the rational development of clinically translatable micelle-based drug delivery systems.

16 January 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
RKRae Hyung Kang
Rae Hyung Kang
SBSeung Woo Baek
Seung Woo Baek
COChang-Kyu Oh
Chang-Kyu Oh
YKYun Hak Kim
Yun Hak Kim
Dokyoung KimDokyoung Kim
Dokyoung Kim
Porous silicon (pSi) has gained substantial attention as a versatile material for various biomedical applications due to its unique structural and functional properties. Initially used as a semiconductor material, pSi has transitioned into a bioactive platform, enabling its use in drug delivery systems, biosensing, tissue engineering scaffolds, and implantable devices. This review explores recent advancements in macrostructural pSi, emphasizing its biocompatibility, biodegradability, high surface area, and tunable properties. In drug delivery, pSi's potential for controlled and sustained release of therapeutic agents has been well-studied, making it suitable for chronic disease treatment. Innovative approaches, like microneedle arrays and hybrid drug delivery systems, are highlighted, along with challenges, such as scalability and stability, in biological environments. pSi-based biosensors offer exceptional sensitivity for detecting biomarkers, benefiting early disease diagnosis. In tissue engineering, fibrous and particulate pSi scaffolds mimic the extracellular matrix, promoting cell proliferation and tissue regeneration. pSi is also gaining momentum in orthopedic implants, demonstrating the potential for bone regeneration. Despite its promise, challenges like mechanical strength, scalability, and long-term stability must be addressed. Looking forward, future research should focus on optimizing production methods, enhancing stability, and exploring hybrid materials for pSi, paving the way for its widespread clinical use in personalized medicine, advanced drug delivery, and next-generation biosensors and implants.

15 February 2019 in Materials
Verified
Journal Article
Open access
PDF file
RKRae Hyung Kang
Rae Hyung Kang
SLSeo Hyeon Lee
Seo Hyeon Lee
SKSangrim Kang
Sangrim Kang
JKJinyoung Kang
Jinyoung Kang
JHJunho K. Hur
Junho K. Hur
Dokyoung KimDokyoung Kim
Dokyoung Kim
Porous silicon nanoparticles (pSiNPs) have been utilized within a wide spectrum of biological studies, as well as in chemistry, chemical biology, and biomedical fields. Recently, pSiNPs have been constantly coming under the spotlight, mostly in biomedical applications, due to their advantages, such as controlled-release drug delivery in vivo by hydrolysis-induced degradation, self-reporting property through long life-time photoluminescence, high loading efficiency of substrate into pore, and the homing to specific cells/organ/bacteria by surface functionalization. However, the systematic degradation rate analysis of surface-functionalized pSiNPs in different biological media has not been conducted yet. In this paper, we prepared four different surface-functionalized pSiNPs samples and analyzed the degradation rate in six different media (DI H2O (deionized water), PBS (phosphate-buffered saline), HS (human serum), DMEM (Dulbecco’s modified Eagle’s medium), LB (lysogeny broth), and BHI (brain heart infusion)). The obtained results will now contribute to understanding the correlation between surface functionalization in the pSiNPs and the degradation rate in different biological media. The characterized data with the author’s suggestions will provide useful insights in designing the new pSiNPs formulation for biomedical applications.

26 November 2022 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
JOJi Hyeon Oh
Ji Hyeon Oh
HUHyeji Um
Hyeji Um
YPYoon Kyung Park
Yoon Kyung Park
MKMin Kim
Min Kim
DKDopil Kim
Dopil Kim
Dokyoung KimDokyoung Kim
Dokyoung Kim

19 November 2025 in ACS Nano
Verified
Journal Article
Open access
RKRae Hyung Kang
Rae Hyung Kang
MRMorteza Rasoulianboroujeni
Morteza Rasoulianboroujeni
MKMaryam Kianpour
Maryam Kianpour
LRLauren Repp
Lauren Repp
SPSuzanne Ponik
Suzanne Ponik
GKGlen Kwon
Glen Kwon
Triple-negative breast cancer (TNBC) remains a significant clinical challenge due to its high aggressiveness, poor prognosis, and lack of targeted therapies. Combining paclitaxel (PTX) with rapamycin (RAP), a PI3K/AKT/mTOR pathway inhibitor, has shown promise in preclinical and clinical studies, but the approach is limited by pharmacokinetic disparities and toxicity concerns. Here, we introduce Rapaxane, a formulation composed of polymeric micelles coloaded with oligo(lactic acid)8 conjugated prodrugs of PTX (oLA8-PTX) and RAP (oLA8-RAP) at an optimized synergistic ratio (5:1). We evaluated the efficacy of Rapaxane in vitro and in preclinical TNBC models, comparing it to the benchmark formulation Abraxane, the combination of parent drugs, and monotherapies using the prodrugs. In vitro, Rapaxane demonstrated notable cytotoxicity against the 4T1 and MDA-MB-231 TNBC cell lines. Ratiometric encapsulation, stability, synchronized drug release, and conversion were confirmed using dynamic light scattering (DLS) and reverse-phase high-performance liquid chromatography (RP-HPLC). Hemolysis assays indicated negligible toxicity, confirming the safety of Rapaxane for intravenous administration. In vivo, Rapaxane significantly reduced tumor growth and metastasis while improving survival rates in subcutaneous and orthotopic TNBC mouse models. Histological analysis using H&E staining, complemented by Ki-67 immunohistochemical staining, demonstrated effective inhibition of lung metastasis in Rapaxane-treated groups compared to control groups. Rapaxane's ability to maintain precise ratiometric dosing, sustain drug release, and enhance therapeutic efficacy while mitigating adverse effects underscores its potential as a next-generation therapy for TNBC. This study highlights the feasibility of nanotechnology-based ratiometric drug delivery systems in overcoming the limitations of conventional combination therapies, paving the way for more effective treatment options for aggressive cancers like TNBC.

2 October 2021 in Materials
Verified
Journal Article
Open access
PDF file
RKRae Hyung Kang
Rae Hyung Kang
Dokyoung KimDokyoung Kim
Dokyoung Kim
Organic solvents with high purity are essential in various fields such as optical, electronic, pharmaceutical, and chemical areas to prevent low-quality products or undesired side-products. Constructing methods to remove impurities such as water residue in organic solvents has been a significant challenge. Within this article, we report for the first time a new method for the preparation of hydrophobic and oleophilic filter paper (named OCFP), based on thermally induced silane dehydrocoupling between cellulose-based filter paper and octadecylsilane. We comprehensively characterized OCFP using various characterization techniques (FTIR, XPS, XRD, and EDS). OCFP showed super-hydrophobic and oleophilic properties as well as remarkable water separation and removal efficiency (>93%) in various organic solvents with sustained reusability. In addition, the analytical results both before and after filtration of an NMR solvent using OCFP indicated that OCFP has an excellent solvent drying efficiency. This work presents a new strategy for the development of super-hydrophobic cellulose-based filter paper, which has great potential for solvent drying and water separation.